Search results
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
Zacks via Yahoo Finance· 3 months agoASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with...
Apellis' (APLS) Q3 Earnings Miss Estimates, Revenues Top Mark
Zacks via Yahoo Finance· 2 years agoApellis Pharmaceuticals, Inc. APLS reported a loss per share of $1.75 for third-quarter 2022, wider...
Regeneron's (REGN) sBLA for Evkeeza Gets FDA Priority Review
Zacks via Yahoo Finance· 1 year agoThe FDA accepts for priority review Regeneron's (REGN) sBLA for Evkeeza for treating children aged...
Apellis (APLS) Files MAA for Pegcetacoplan in GA in Europe
Zacks via Yahoo Finance· 1 year agoApellis (APLS) submits a marketing authorization application for pegcetacoplan to treat geographic...
Nabriva (NBRV) Posts Positive Data From Cystic Fibrosis Study
Zacks via Yahoo Finance· 2 years agoNabriva (NBRV) posts positive top-line data from the phase I study evaluating oral and intravenous...